CAMBRIDGE, Mass.--(BUSINESS WIRE)--Kyn Therapeutics, a biotechnology company advancing new immunometabolism therapies for treating cancer, today announced $49 million in Series A capital available to ...

Forbes contributors publish independent expert analyses and insights. We provide aggregated data on dividend stocks. The report stated, ''Dividend investors approaching investing from a value ...

This morning a "Potential Dividend Run Alert" went out for Kayne Anderson MLP Investment Company (NYSE: KYN), at our DividendChannel.com Dividend Alerts service (a free email alerts feature). Let's ...

BOSTON--(BUSINESS WIRE)--Kyn Therapeutics, a clinical-stage biotechnology company advancing research into new immunometabolic therapies for treating cancer, today announced it has entered into a ...

The Kayne Anderson Energy Infrastructure Fund is rated a Buy due to its strong total returns, high yield, and discount to NAV. The KYN closed-end fund benefits from stable, contracted cash flows and ...

KYN offers strong long-term exposure to the midstream energy sector, with industry-leading 10-year returns and a focus on stable, fee-based businesses. The fund trades at a persistent discount to NAV, ...

HOUSTON, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (NYSE: KYN) (the “Company”) announced today that the Company’s name has been changed from Kayne Anderson MLP ...

CARSON CITY, NV, April 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – KYN Capital Group (OTC: KYNC) is pleased to announce that BW Property Management Group, the developer of Pay.How, has been ...

Kayne Anderson Energy Infrastructure Fund Inc. Annual cash flow by MarketWatch. View KYN net cash flow, operating cash flow, operating expenses and cash dividends.

CARSON CITY, NV, Oct. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – KYN Capital Group (OTC:KYNC) is excited to announce that phase one of its commission-free cryptocurrency exchange is now available ...